Target Name: VEGFD
NCBI ID: G2277
Review Report on VEGFD Target / Biomarker Content of Review Report on VEGFD Target / Biomarker
VEGFD
Other Name(s): FIGF | Vascular endothelial growth factor D | vascular endothelial growth factor D | VEGF-D | c-Fos-induced growth factor | c-fos induced growth factor (FIGF) | c-fos induced growth factor (vascular endothelial growth factor D) | VEGFD_HUMAN

VEGF: A Protein Essential for Blood Vessel Development and Maintenance

Vascular endothelial growth factor (VEGF) is a protein that plays a crucial role in the development and maintenance of blood vessels. It is a transmembrane glycoprotein that is expressed in the endothelial cells of the vascular system, including arteries, veins, and capillaries. VEGF is involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed.

VEGF is a potent stimulator of vascular endothelial growth and permeability. Its stimulatory effect is mainly reflected in promoting the growth and permeability of vascular endothelial cells. This property makes VEGF a very attractive drug target because scientists have found that VEGF can stimulate the growth and permeability of vascular endothelial cells, leading to an increase in vascular permeability.

VEGF鈥檚 mechanism of action

The mechanism of action of VEGF is very complex and involves multiple signaling pathways. These include:

1. Vascular endothelial growth factor receptor (VEGFR) signaling pathway

VEGF binds to its receptor tyrosine kinase (EGFR), thereby activating EGFR kinase. This results in activation of EGFR kinase, which results in a cascade of signaling. These signals include: phosphorylation of EGFR kinase, tyrosine phosphorylation of EGFR kinase, recruitment of EGFR kinase, and increased stability of EGFR kinase.

2. Vascular endothelial growth factor receptor (VEGFR) signaling pathway

VEGF binds to its receptor tyrosine kinase (EGFR), thereby activating EGFR kinase. This results in activation of EGFR kinase, which results in a cascade of signaling. These signals include: phosphorylation of EGFR kinase, tyrosine phosphorylation of EGFR kinase, recruitment of EGFR kinase, and increased stability of EGFR kinase.

3. Vascular endothelial growth factor receptor (VEGFR) signaling pathway

VEGF binds to its receptor tyrosine kinase (EGFR), thereby activating EGFR kinase. This results in activation of EGFR kinase, which results in a cascade of signaling. These signals include: phosphorylation of EGFR kinase, tyrosine phosphorylation of EGFR kinase, recruitment of EGFR kinase, and increased stability of EGFR kinase.

VEGF and disease

VEGF plays an important role in a variety of diseases, including:

1. Angiogenesis

VEGF is a key factor in angiogenesis. It stimulates endothelial cell growth and increased permeability, leading to angiogenesis.

2. Cardiovascular disease

VEGF is involved in the occurrence and development of cardiovascular diseases. Research shows that elevated VEGF levels are a risk factor for cardiovascular disease.

3. Tumor growth

VEGF is a key factor in tumor growth. It can promote the growth and metastasis of tumor cells.

4. Skin diseases

VEGF also plays an important role in skin diseases. It promotes the growth and permeability of skin cells, leading to skin lesions.

VEGF treatment

VEGF has multiple drug targets and therefore can be used to treat a variety of diseases. These include:

1. Treat cardiovascular disease

VEGF receptor antagonists have been widely used to treat cardiovascular diseases, including atherosclerosis and myocardial infarction. Studies have shown that VEGF receptor antagonists can lower blood lipids, lower blood pressure, improve heart function and extend survival time.

2. Treat skin diseases

VEGF receptor antagonists are also widely used to treat skin diseases, including acne, skin aging, and skin cancer. Research shows that VEGF receptor antagonists can inhibit the growth and migration of skin cells, thereby improving skin health.

3. Treat cancer

VEGF receptor antagonists are also widely used to treat cancer, including breast, lung and ovarian cancer. Studies have shown that VEGF receptor antagonists can inhibit the growth and metastasis of tumor cells, thereby prolonging survival time.

4. Prevent eye diseases

VEGF receptor antagonists are also widely used to prevent eye diseases, including corneal pathology and macular degeneration. Studies have shown that VEGF receptor antagonists can inhibit the growth and migration of eye cells, thereby preventing eye diseases.

Biological effects of VEGF

VEGF plays important roles in biology, including:

1. Regulate immune cells

VEGF can stimulate immune cell activity

Protein Name: Vascular Endothelial Growth Factor D

Functions: Growth factor active in angiogenesis, lymphangiogenesis and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR/FLK1) and VEGFR-3 (FLT4) receptors

The "VEGFD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VEGFD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

VENTX | VENTXP1 | VENTXP7 | VEPH1 | VEZF1 | VEZT | VGF | VGLL1 | VGLL2 | VGLL3 | VGLL4 | VHL | VIL1 | VILL | VIM | VIP | VIPAS39 | VIPR1 | VIPR1-AS1 | VIPR2 | VIRMA | VIT | VKORC1 | VKORC1L1 | VLDLR | VLDLR-AS1 | VMA21 | VMAC | VMO1 | VMP1 | VN1R1 | VN1R101P | VN1R108P | VN1R10P | VN1R11P | VN1R12P | VN1R17P | VN1R18P | VN1R2 | VN1R4 | VN1R46P | VN1R5 | VN1R82P | VN1R91P | VN1R96P | VN2R11P | VN2R1P | VN2R3P | VNN1 | VNN2 | VNN3P | Voltage-dependent anion channels (Porins) | Voltage-dependent calcium channel gamma subunit | Voltage-gated K(v) channel | Voltage-Gated Sodium Channel Complex | Volume-Regulated Anion Channel (VRAC) | VOPP1 | VOR Complex | VPREB1 | VPREB3 | VPS11 | VPS13A | VPS13A-AS1 | VPS13B | VPS13C | VPS13C-DT | VPS13D | VPS16 | VPS18 | VPS25 | VPS26A | VPS26AP1 | VPS26B | VPS26C | VPS28 | VPS29 | VPS33A | VPS33B | VPS35 | VPS35L | VPS36 | VPS37A | VPS37B | VPS37C | VPS37D | VPS39 | VPS41 | VPS45 | VPS4A | VPS4B | VPS50 | VPS51 | VPS51P8 | VPS52 | VPS53 | VPS54 | VPS72 | VPS8 | VPS9D1 | VPS9D1-AS1